(Q73194059)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10566561%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

title

Current opinions on therapeutic drug monitoring of immunosuppressive drugs (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10566561%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

author name string

L M Shaw

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10566561%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

D W Holt

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10566561%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

P Keown

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10566561%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

R Venkataramanan

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10566561%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

R W Yatscoff

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10566561%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

publication date

1 October 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10566561%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

published in

Clinical Therapeutics

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10566561%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

volume

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10566561%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10566561%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

page(s)

1632-52; discussion 1631

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10566561%20AND%20SRC:MED&resulttype=core&format=json

Lake Louise Consensus Conference on cyclosporin monitoring in organ transplantation: report of the consensus panel.

2 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980044-7

7 January 2021

The relative effects of FK506 and cyclosporine on short- and long-term kidney graft survival

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980044-7

7 January 2021

Optimization of cyclosporine therapy with new therapeutic drug monitoring strategies: report from the International Neoral TDM Advisory Consensus Meeting (Vancouver, November 1997).

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980044-7

7 January 2021

Therapeutic monitoring of mycophenolic acid. A consensus panel report

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980044-7

7 January 2021

Analysis, pharmacokinetics and therapeutic drug monitoring of mycophenolic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980044-7

7 January 2021

Rapamycin: distribution, pharmacokinetics, and therapeutic range investigations.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980044-7

7 January 2021

Consensus guidelines for therapeutic drug monitoring of rapamycin: report of the consensus panel.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980044-7

7 January 2021

A Comparison of Tacrolimus (FK 506) and Cyclosporine for Immunosuppression in Liver Transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980044-7

7 January 2021

A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. FK506 Kidney Transplant Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980044-7

7 January 2021

Liver, kidney, and thoracic organ transplantation under FK 506.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980044-7

7 January 2021

FK 506 for liver, kidney, and pancreas transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980044-7

7 January 2021

Clinical pharmacokinetics of tacrolimus

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980044-7

7 January 2021

Optimal FK 506 dosage in patients under primary immunosuppression following liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980044-7

7 January 2021

Tacrolimus: a new immunosuppressive agent.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980044-7

7 January 2021

The pharmacokinetic-pharmacodynamic relationship for mycophenolate mofetil in renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980044-7

7 January 2021

Limited sampling strategy for the determination of mycophenolic acid area under the curve in pediatric kidney recipients. German Study Group on MMF Therapy in Pediatric Renal Transplant Recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980044-7

7 January 2021

Role of immunophilins in therapeutic drug monitoring of immunosuppressive drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980044-7

7 January 2021

Influence of cyclosporine pharmacokinetics, trough concentrations, and AUC monitoring on outcome after kidney transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980044-7

7 January 2021

Challenges in cyclosporine therapy: the role of therapeutic monitoring by area under the curve monitoring.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980044-7

7 January 2021

Variable oral absorption of cyclosporine. A biopharmaceutical risk factor for chronic renal allograft rejection

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980044-7

7 January 2021

Improved dose linearity of cyclosporine pharmacokinetics from a microemulsion formulation

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980044-7

7 January 2021

A randomized, prospective multicenter pharmacoepidemiologic study of cyclosporine microemulsion in stable renal graft recipients. Report of the Canadian Neoral Renal Transplantation Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980044-7

7 January 2021

Consistent absorption of cyclosporine from a microemulsion formulation assessed in stable renal transplant recipients over a one-year study period

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980044-7

7 January 2021

Neoral vs Sandimmun: interim results of a randomized trial of efficacy and safety in preventing acute rejection in new renal transplant recipients. The U. K. Neoral Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980044-7

7 January 2021

A microemulsion of cyclosporine without intravenous cyclosporine in liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980044-7

7 January 2021

Simple bioequivalence criteria: are they relevant to critical dose drugs? Experience gained from cyclosporine

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980044-7

7 January 2021

Intra- and interindividual variation in the pharmacokinetics of tacrolimus (FK506) in kidney transplant recipients--importance of trough level as a practical indicator

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980044-7

7 January 2021

Racial variation in dosage requirements of tacrolimus

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980044-7

7 January 2021

Differentiation of absorption and first-pass gut and hepatic metabolism in humans: Studies with cyclosporine*

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980044-7

7 January 2021

Tacrolimus oral bioavailability doubles with coadministration of ketoconazole

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980044-7

7 January 2021

Relationship of FK506 whole blood concentrations and efficacy and toxicity after liver and kidney transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980044-7

7 January 2021

Consensus document: therapeutic monitoring of tacrolimus (FK-506).

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980044-7

7 January 2021

Mycophenolate mofetil. A review of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980044-7

7 January 2021

Pharmacokinetics of mycophenolic acid in renal transplant patients with delayed graft function

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980044-7

7 January 2021

Decreased protein binding of mycophenolic acid associated with leukopenia in a pancreas transplant recipient with renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980044-7

7 January 2021

Is the glucuronide metabolite of MPA pharmacologically active?

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980044-7

7 January 2021

Effect of mycophenolic acid glucuronide on inosine monophosphate dehydrogenase activity

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980044-7

7 January 2021

A BLINDED, RANDOMIZED CLINICAL TRIAL OF MYCOPHENOLATE MOFETIL FOR THE PREVENTION OF ACUTE REJECTION IN CADAVERIC RENAL TRANSPLANTATION1

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980044-7

7 January 2021

Pharmacokinetics of sirolimus in stable renal transplant patients after multiple oral dose administration

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980044-7

7 January 2021

Rapamycin: distribution, pharmacokinetics and therapeutic range investigations: an update

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980044-7

7 January 2021

SDZ RAD, a new rapamycin derivative: synergism with cyclosporine

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2899%2980044-7

7 January 2021

10.1016/S0149-2918(99)80044-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10566561%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference